Target intelligence / Profile preview

PARM1 antisense RNA 1 (PARM1-AS1)

Target
PARM1-AS1
Molecular classification
Other (presumed long non-coding RNA, antisense RNA)
01

Overview

PARM1 antisense RNA 1 (PARM1-AS1) is *presumed to be a long non-coding RNA* (lncRNA) transcribed antisense to the PARM1 gene. Antisense lncRNAs can regulate the expression of their sense partner genes or exert regulatory functions via diverse mechanisms, including chromatin remodeling, transcription interference, or RNA duplex formation[3]. As of the present review, there is *no experimental evidence or peer-reviewed publication discussing the specific characteristics, biological functions, disease relevance, or therapeutic interest in PARM1-AS1*. The gene it is antisense to, PARM1 (prostate androgen-regulated mucin-like protein 1), is a membrane-associated mucin family protein potentially implicated in oncogenic processes[1][2], but **PARM1-AS1** itself is not documented as a protein, receptor, enzyme, transporter, or other canonical drug target. Absence of mention in scientific reporting suggests it may be a predicted, putative, or poorly annotated transcript.\n\n**Key Insights and Limitations:**\n- Many human lncRNAs, especially antisense species, remain poorly characterized and may be annotated in genomic databases without any experimental validation or known biological roles. \n- While antisense RNAs can theoretically affect gene regulation by acting in cis or trans[3], PARM1-AS1 lacks any such studied or reported activity. \n- There is no evidence of PARM1-AS1 being a drug target, disease biomarker, or having roles in human pathophysiology.\n\nIf your query was meant to refer to the protein "PARM1" (rather than the antisense RNA), please clarify, as that is a mucin family protein with some reported functions and disease links[1][2]. For the antisense RNA "PARM1-AS1," the above limitations and absence of evidence apply.

Other names
PARM1-AS1
02

Mechanism of action

none (no drugs targeting this molecule, thus no mechanism of action)

03

Biological functions

Other (general regulatory roles possible for antisense RNAs such as regulation of gene expression, but specific function for PARM1-AS1 is not documented)
04

Disease associations

Other (generic—antisense lncRNAs may be implicated in cancer or regulation of neighboring gene expression, but no specific disease role for PARM1-AS1 is found)

Beyond the preview

Go deeper on PARM1 antisense RNA 1 (PARM1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PARM1 antisense RNA 1 (PARM1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call